Lockheed Martin’s expanding missile backlog and new PAC-3 Edge interceptor strengthen its defense business, supporting growth despite valuation concerns.

Structure Therapeutics has seen a sharp reset in market sentiment this year, which puts fresh focus on whether the current ...

Central bankers now talk openly about higher interest rates as AI infrastructure spending absorbs capital, which puts the ...

ASML Holding reported Q3 2026 revenue of €11,662 million and net income of €4,960.4 million, with management highlighting ...

Intercontinental Exchange reported higher average daily volume and open interest across energy, agriculture, metals, ...

Three key takeaways from management stand out for long-term investors. Software developers at the firm are 25% more ...

The AI chip leader's stock trades around 9% under its record, even after its chipmaker boosted its forecast again.

Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology ...

Truist Financial reported mixed third quarter 2026 results, with EPS of $1.16 slightly below consensus, revenue of $5.19b ...

Mastercard and recently acquired BVNK have launched the Mastercard Global Money Platform, a single API that lets banks, ...

Elbit Systems has moved into the spotlight after the recent Israeli elections, which pitted incumbent Prime Minister Benjamin ...

Lockheed Martin recently delivered a C-130J-30 Super Hercules to the U.S. Navy for conversion into the E-130J Phoenix II ...